The comprehensive analysis confirmed that the SERPINE1 gene is a reliable molecular marker for early diagnosis of aortic coarctation, and based on the molecular mechanism, we speculate that possible new drugs targeting the SERPINE1 gene are possible in the future. This evidence concerns the gene SERPINE1 and aorta coarctation.